Company intelligence / Profile preview

Grove Biopharma

Chicago, Illinois, United Statesgrovebiopharma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has demonstrated in vivo proof-of-concept for its lead androgen receptor signaling program for castrate-resistant prostate cancer and is advancing towards an IND submission[6][7]

Therapeutic areas: OncologyRare DiseasesNeurology
Modalities: Bionic Biologics (synthetic biologics)
Industry: Biotech

Drug pipeline

9 assets

TAU

Preclinical

8 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Grove Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Grove Biopharma.

Explore the full profile